Lobbying client · LD-2 disclosures
Life Sciences Pennsylvania
Pennsylvania
26 filings from 1 registrant · 2020–2026 · latest filed Jul 7, 2026
Reported on its behalf
$35K
every LD-2 on file
Its own filed spend
$35K
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
This organization files only for itself — no outside firm has reported fees for it.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee paid to an outside firm. See the full list.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
26 filings
$35K on those filings
Medical/Disease Research/Clinical Labs
MED
25 filings
$29K on those filings
Medicare/Medicaid
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Kurt Imhof Life Sciences PennsylvaniaCovered position: VP, Policy and Public Affairs19 filingsthrough 2024
- Lara Flynn Life Sciences Pennsylvania16 filingsthrough 2026
Covered positions · 1 of 2 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
The 20 most recent of 26 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: life-sciences-pennsylvania.